HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jia-Huai Wang Selected Research

DCC Receptor

1/2020Netrin Synergizes Signaling and Adhesion through DCC.
1/2018Structural Basis for Draxin-Modulated Axon Guidance and Fasciculation by Netrin-1 through DCC.
8/2014The crystal structure of netrin-1 in complex with DCC reveals the bifunctionality of netrin-1 as a guidance cue.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jia-Huai Wang Research Topics

Disease

4Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 08/2014
2Human Influenza (Influenza)
01/2021 - 05/2009
2Neoplasms (Cancer)
01/2020 - 09/2014
2Infections
10/2016 - 03/2008
1Fasciculation (Fasciculations)
01/2018
1Down Syndrome (Down's Syndrome)
01/2016
1Sepsis (Septicemia)
01/2015
1Stroke (Strokes)
01/2015
1Vascular Diseases (Vascular Disease)
09/2014
1Vascular Remodeling
08/2012
1Vesicular Stomatitis
01/2011
1Leukemia
03/2005
1Inflammation (Inflammations)
01/2004

Drug/Important Bio-Agent (IBA)

3DCC ReceptorIBA
01/2020 - 08/2014
3Netrin-1IBA
01/2018 - 08/2014
2NetrinsIBA
01/2020 - 01/2018
2IntegrinsIBA
08/2012 - 01/2004
2Histocompatibility Antigens Class IIBA
01/2011 - 03/2005
1Nucleic AcidsIBA
01/2021
1NucleoproteinsIBA
01/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1HLA-B Antigens (HLA-B)IBA
10/2016
1Cell Adhesion Molecule-1IBA
01/2016
1Terazosin (Hytrin)FDA LinkGeneric
01/2015
1Pharmaceutical PreparationsIBA
01/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2014
1Proteins (Proteins, Gene)FDA Link
05/2009
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
03/2008
1CD8alphabeta antigenIBA
03/2005
1AntigensIBA
03/2005
1Biological ProductsIBA
01/2004

Therapy/Procedure

1Immunotherapy
01/2020